Autopsy report · NCT01606124
Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
Cause of deathDrug or device supply
“pending expiration of the supply of study agent.”
Life of this trial
- Ran for about 2 years 11 months before it stopped.
- 39 participants enrolled.
- Results were posted on the registry 2 years 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Advanced Colorectal Adenomas; Adenocarcinoma of the Colon; Stage I Colon Cancer; Stage II Colon Cancer; Stage III Colon Cancer
- Interventions
- defined green tea catechin extract; placebo; questionnaire administration; laboratory biomarker analysis
- Participants
- 39
- Sites
- 3
- Countries
- United States
Trials that died the same way
- Cannabinoids in PLWHIV on Effective ART
“expiration of study product; end of study product availability” - Optimal Timing of BR55 CEUS of the Ovaries
“Sponsor decision; expiration of available study agent due to long recruitment timeline.” - Epidural Technique: Does it Really Matter to the Patient?
“This study was terminated early because of shortage of supplies with no foreseeable future of when they will be back in stock.” - The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention
“IRB approval expired on 3/16/2022. Study would need to be reapproved by the IRB with a new submission given the duration of expiration.” - Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
“Study discontinued due to futility.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.